A DC Circuit court upheld a federal judge’s ruling striking down the Department of Health and Human Services’ new rule requiring drug companies to disclose the price of a 30 day supply in

A new court filing against big American pharmacy retailers has been submitted in the multi-district litigation in Ohio Federal Court overseen by Judge Dan Polster. The complaint accuses major pharmacies, including CVS, Rite

April 2020 Update: Stephen Sheller has been recognized by the American Association for Justice with AAJ’s 2019 Top Verdict Award. “Each year, American Association for Justice releases the Top Verdicts Litigation Packet, featuring

A recent ProPublica investigative report calls into question the Trump Administration’s commitment to ending the opioid crisis, criminally charging those responsible, and ensuring that protections are in place to prevent another crisis. Even

The Pennsylvania Supreme Court declined to hear Janssen Pharmacuetical’s request for an appeal of a lower courts decision to reinstate the lawsuit of a Texas man who took Risperdal as a child. The Pennsylvania Superior Court’s decision to allow

In a rare admission to PBS Frontline & the Finical Times, a pharmaceutical executive acknowledged that he knowingly orchestrated an illegal scheme to boost sales of a powerful opiate painkiller believing there would be no

Philadelphia Court of Common Pleas Judge Kenneth Powell reduced an October 2019 $8 billion punitive damages verdict against J&J to $6.8 million. A jury had awarded the figure over allegations that J&J’s drug

Plaintiffs’ in the multi-district litigation, which consisting of more than 2,500 cities and counties, suing opioid manufacturers and distributors for their role in the opioid crisis find they have conflicting goals with state lawmakers

The Stephen and Sandra Sheller 11th Street Family Health Services of Drexel University is one of the many ways that the Sheller family gives back to the community. Since the health center’s inception

A Pennsylvania Superior Court has rejected Johnson & Johnson’s appeal of a 2016 $70 million verdict awarded to a 20 year-old Tennessee man, Andrew Yount (A.Y.) who developed gynecomastia after taking the antipsychotic